首页> 外文期刊>Neuropathology and applied neurobiology >Return of the cycad hypothesis - does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?
【24h】

Return of the cycad hypothesis - does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?

机译:苏铁的假设的回归-关岛的肌萎缩性侧索硬化/帕金森氏痴呆综合症(ALS / PDC)是否会对全球健康产生新的影响?

获取原文
获取原文并翻译 | 示例
           

摘要

Recently published work provides evidence in support of the cycad hypothesis for Lytico--Bodig, the Guamanian amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC), based on a new understanding of Chamorro food practices, a cyanobacterial origin of beta-methylaminoalanine (BMAA) in cycad tissue, and a possible mechanism of biomagnification of this neurotoxic amino acid in the food chain. BMAA is one of two cycad chemicals with known neurotoxic properties (the other is cycasin, a proven developmental neurotoxin) among the many substances that exist in these highly poisonous plants, the seeds of which are used by Chamorros for food and medicine. The traditional diet includes the fruit bat, a species that feeds on cycad seed components and reportedly bioaccumulates BMAA. Plant and animal proteins provide a previously unrecognized reservoir for the slow release of this toxin. BMAA is reported in the brain tissue of Guam patients and early data suggest that some Northern American patients dying of Alzheimer's disease (AD) have detectable brain levels of BMAA. The possible role of cyanobacterial toxicity in sporadic neurodegenerative disease is therefore worthy of consideration. Recent neuropathology studies of ALS/PDC confirm understanding of this disorder as a 'tangle' disease, based on variable anatomical burden, and showing biochemical characteristics of 'AD-like' combined 3R and 4R tau species. This model mirrors the emerging view that other neurodegenerative disease spectra comprise clusters of related syndromes, owing to common molecular pathology, with variable anatomical distribution in the nervous system giving rise to different clinical phenotypes. Evidence for 'ubiquitin-only' inclusions in ALS/PDC is weak. Similarly, although there is evidence for alpha-synucleinopathy in ALS/PDC, the parkinsonian component of the disease is not caused by Lewy body disease. The spectrum of sporadic AD includes involvement of the substantia nigra and a high prevalence of 'incidental'alpha-synucleinopathy in sporadic AD is reported. Therefore the pathogenesis of Lytico-Bodig appears still to have most pertinence to the ongoing investigation of the pathogenesis of AD and other tauopathies.
机译:最近发表的工作提供了证据来支持Lytico-Bodig的苏铁的假说,这是一种对瓜莫尼州的肌萎缩性侧索硬化/帕金森氏病性痴呆复合体(ALS / PDC)的苏铁假说,其基于对Chamorro食品实践(β-甲基氨基丙氨酸的蓝细菌起源)的新认识苏铁组织中的BMAA),以及在食物链中这种神经毒性氨基酸被生物放大的可能机制。 BMAA是存在于这些剧毒植物中的许多物质中,两种具有已知神经毒性特性的苏铁化学物质之一(另一种是cycasin,一种经证实的发育神经毒素),Chamorros将其种子用于食品和药品。传统饮食包括果蝠,该果蝠以苏铁种子成分为食,据报道生物积累了BMAA。植物和动物蛋白为这种毒素的缓慢释放提供了以前无法识别的贮藏库。据报道,关岛患者的大脑组织中存在BMAA,早期数据表明,一些死于阿尔茨海默氏病(AD)的北美患者的脑中BMAA水平可检测。因此,值得考虑的是蓝细菌毒性在散发性神经退行性疾病中的可能作用。最近的ALS / PDC神经病理学研究证实,基于可变的解剖负担,该疾病被理解为“缠结”疾病,并显示出“ AD样” 3R和4R tau结合物种的生化特征。该模型反映了一种新的观点,即由于常见的分子病理学,其他神经退行性疾病谱包括相关综合症的簇,神经系统中解剖结构的变化会引起不同的临床表型。 ALS / PDC中“仅泛素化”夹杂物的证据很少。同样,尽管有证据表明ALS / PDC中存在α-突触核蛋白病,但帕金森病并非由路易体病引起。散发性AD的频谱包括黑质的侵袭,据报道散发性AD中“偶发性”α-突触核蛋白病的患病率很高。因此,Lytico-Bodig的发病机制似乎仍与正在进行的AD和其他疾病的发病机制研究最为相关。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号